APA

Yang P., Chen C., Hou C., Lin Y. & Tsui K. (20180723). An open-label, prospective interventional study of the tolerability and efficacy of 0.4 mg oral tamsulosin oral controlled absorption system in men with lower urinary tract symptoms associated with benign prostatic hyperplasia who are unsatisfied with treatment with 0.2 mg tamsulosin. : Clinical interventions in aging.

Chicago

Yang Pei-Shan, Chen Chien-Lun, Hou Chen-Pang, Lin Yu-Hsiang and Tsui Ke-Hung. 20180723. An open-label, prospective interventional study of the tolerability and efficacy of 0.4 mg oral tamsulosin oral controlled absorption system in men with lower urinary tract symptoms associated with benign prostatic hyperplasia who are unsatisfied with treatment with 0.2 mg tamsulosin. : Clinical interventions in aging.

Harvard

Yang P., Chen C., Hou C., Lin Y. and Tsui K. (20180723). An open-label, prospective interventional study of the tolerability and efficacy of 0.4 mg oral tamsulosin oral controlled absorption system in men with lower urinary tract symptoms associated with benign prostatic hyperplasia who are unsatisfied with treatment with 0.2 mg tamsulosin. : Clinical interventions in aging.

MLA

Yang Pei-Shan, Chen Chien-Lun, Hou Chen-Pang, Lin Yu-Hsiang and Tsui Ke-Hung. An open-label, prospective interventional study of the tolerability and efficacy of 0.4 mg oral tamsulosin oral controlled absorption system in men with lower urinary tract symptoms associated with benign prostatic hyperplasia who are unsatisfied with treatment with 0.2 mg tamsulosin. : Clinical interventions in aging. 20180723.